Publications by authors named "Matthew D Seftel"

Claim this Profile
U
Use of non-qualifying umbilical cord blood units to support research and quality assurance by the Canadian Blood Services Cord Blood Bank.
David S Allan, Matthew D Seftel, An Duong, Harinad Maganti, Kathy Ganz

Transfusion· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.
Matthew D Seftel, Grace Musto, David Allan, Oliver Bucher, Kevin Hay

Curr Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruiting blood donors to the Canadian Blood Services Stem Cell Registry: A feasibility assessment.
Gaganvir Parmar, Meagan Green, Kathy Ganz, Matthew D Seftel, David S Allan

Transfusion· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice.
Adam Cuker, Robert Kunkle, Rachel S Bercovitz, Michael Byrne, Benjamin Djulbegovic, Matthew D Seftel

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity, equity, and inclusion in ASH guidelines.
Matthew D Seftel, Deirdra Terrell, Adam Cuker, Matthew Cheung, Menaka Pai

Lancet Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation.
Gaganvir Parmar, Matthew D Seftel, Kathy Ganz, John Blake, Jelena L Holovati

Curr Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Genovefa A Papanicolaou, Min Chen, Naya He, Michael J Martens, Soyoung Kim, Matthew D Seftel

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplantation cyclophosphamide is associated with increased bacterial infections.
Celalettin Ustun, Min Chen, Soyoung Kim, Jeffery J Auletta, Marjorie V Batista, Matthew D Seftel

Bone Marrow Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility.
Adrian J M Bailey, John Blake, Kathy Ganz, Matthew D Seftel, David S Allan

Transfusion· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.
Matthew D Seftel, Ivan Pasic, Gaganvir Parmar, Oliver Bucher, David S Allan

Curr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups.
John T Blake, Gaganvir Parmar, Kathy Ganz, Matthew D Seftel, David S Allan

Transfusion· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety.
Gaganvir Parmar, David S Allan, Gail Morris, Nicholas Dibdin, Kathy Ganz, Matthew D Seftel

Curr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services' Cord Blood Bank: First Analysis.
Gaganvir Parmar, Meagan Green, Karen Mostert, Tiffany Lawless, Nicholas Dibdin, Matthew D Seftel

Curr Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure.
Jasmine Candeliere, Aidan M Kirkham, Risa Shorr, Gail Morris, Philip Berardi, Matthew D Seftel

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in Canada.
Graeme Ball, Christopher Lemieux, David Cameron, Matthew D Seftel

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Matthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, Matthew D Seftel

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Kevin Brown, Matthew D Seftel, Kevin A Hay

CMAJ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T).
Kevin Brown, Matthew D Seftel, Kevin A Hay

CMAJ· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients With Acute Promyelocytic Leukemia in South Africa.
Rory Shein, Nomusa Mashigo, Cecile E du Toit, Jenna Oosthuizen, Matthew D Seftel

Clin Lymphoma Myeloma Leuk· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A century between pandemics and poisonings.
Matthew D Seftel, Vernon Louw

Lancet Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has MRD graduated from its adolescence in ALL?
Matthew D Seftel

Blood· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.
Matthew D Seftel, Pintip Chitphakdithai, John P Miller, Hati Kobusingye, Brent R Logan

Transplant Cell Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyper-CVAD: a regimen for all seasons.
Matthew D Seftel

Lancet Haematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.
Matthew D Seftel, Michelle Kuxhausen, Linda Burns, Pintip Chitphakdithai, Dennis Confer

Biol Blood Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.
Matthew D Seftel

CMAJ· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis